Annovis Bio, Inc. (ANVS) Operating cash flow 2019–2025
Annovis Bio, Inc. (ANVS) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$25.6MFY2025 · since FY2019: -$476,542 → -$25.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$25.6M | -17.0% |
| FY2024 | -$21.9M | +45.2% |
| FY2023 | -$40.0M | -130.9% |
| FY2022 | -$17.3M | -89.6% |
| FY2021 | -$9.1M | -130.0% |
| FY2020 | -$4.0M | -733.3% |
| FY2019 | -$476,542 | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More ANVS financial trends
ANVS RevenueANVS Net incomeANVS Net marginANVS Gross profitANVS Gross marginANVS Operating incomeANVS Operating marginANVS Free cash flowANVS Capital expendituresANVS Return on equityANVS Stock buybacksANVS Dividends paidANVS Total assetsANVS Total liabilitiesANVS Shareholders’ equityANVS overview →